A

Abeona Therapeutics
D

ABEO

5.78000
USD
-0.04
(-0.69%)
مغلق
حجم التداول
7,609
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
251,262,553
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    N
    NTLA
    -0.075
    (-0.61%)
    12.180 USD
    Q
    QURE
    -0.130
    (-1.00%)
    12.840 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    R
    RGNX
    -0.08500
    (-1.15%)
    7.28000 USD
    S
    SGMO
    -0.04500
    (-4.00%)
    1.08000 USD
    V
    VYGR
    -0.04000
    (-0.94%)
    4.22500 USD
    المزيد
الأخبار
المقالات

العنوان: Abeona Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.